Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Hempdocon Aug 23, 2020 8:51pm
233 Views
Post# 31444150

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Covid 19 IS the promotor

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Covid 19 IS the promotor

Pandora wrote:
Well it was a bit of a non-event type of announcement.

The well publicized event turned out to be an announcement of Early Use Authorization (EUA) for convalescent plasma. This is received not unlike HCQ. It has been around for 100 years and has been discussed for a couple of months. It has not gone through a controlled study so the nay sayers are jumping on that immediately. A doctor from Vanderbilt University was interviewed and he has stated that he would not accept "anything" for "anything" until it has gone through all of the rigours of a full blown controlled placebo type study. He is not willing to short cut anything -- and the number of deaths happening does not appear to influence his thinking.

I was kind of hoping for an anouncement of a new well documented drug showing very good results - relatively speaking. The plasma routine supposedly has about a 35% reduction factor which the "experts" claim is very good.

 

That Vanderbilt doc is not willing to shortcut anything, but he & too many remain selfishly silent/ignorant (when they should be shouting) about the need for placebo-controlled/unbiased RCTs of HCQ as a combo drug in the well-known "triple drug" regimen...a regimen used during the "early" stages of illness.  While objectivity/unbias is important in any clinical trial, the goal of saving lives gets eroded by this apparent & persistent ignorance/suppression of the potential benefits of early intervention.  This is a real black eye for medical science & all of its contributors imo.

Pandora...you may find the following interesting:

https://uncommondescent.com/medicine/the-frontline-doctors-put-some-plausible-mechanisms-for-hydroxychloroquine-on-the-table/

Bullboard Posts